Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wessels

Showing results (191-200 of 338) with videos related to

Pageof 34
Sort By:
Nature Methods|April 15, 2014
Multiscale representation of genomic signalsTheo A Knijnenburg, Stephen A Ramsey, Benjamin P Berman, et al.
Plos One|November 9, 2018
Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint associationDavid M Vossen, Caroline V M Verhagen, Reidar Grénman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Functional Categorization of <i>BRCA1</i> Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation AssaysPeter Bouwman, Ingrid van der Heijden, Hanneke van der Gulden, et al.
Lancet (London, England)|November 18, 1989
Immunological study of dystrophin in Duchenne fetusI B Ginjaar, E Bakker, J T den Dunnen, et al.
British Journal of Cancer|September 29, 2005
No common denominator for breast cancer lymph node metastasisB Weigelt, L F A Wessels, A J Bosma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Correction: Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation AssaysPeter Bouwman, Ingrid van der Heijden, Hanneke van der Gulden, et al.
Cell Research|May 26, 2018
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer modelsZheng Xue, Daniel J Vis, Alejandra Bruna, et al.
Molecular Cancer Therapeutics|March 16, 2019
Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with CisplatinRemco Nagel, Ana Teresa Avelar, Nanne Aben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2024
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung CancerJoris van de Haar, Joanne M Mankor, Karlijn Hummelink, et al.
Nucleic Acids Research|June 10, 2011
Computational identification of insertional mutagenesis targets for cancer gene discoveryJohann de Jong, Jeroen de Ridder, Louise van der Weyden, et al.
Pageof 34

Showing results (191-200 of 338) with videos related to

Sort By:
Pageof 34
Nature Methods|April 15, 2014
Multiscale representation of genomic signalsTheo A Knijnenburg, Stephen A Ramsey, Benjamin P Berman, et al.
Plos One|November 9, 2018
Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint associationDavid M Vossen, Caroline V M Verhagen, Reidar Grénman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Functional Categorization of <i>BRCA1</i> Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation AssaysPeter Bouwman, Ingrid van der Heijden, Hanneke van der Gulden, et al.
Lancet (London, England)|November 18, 1989
Immunological study of dystrophin in Duchenne fetusI B Ginjaar, E Bakker, J T den Dunnen, et al.
British Journal of Cancer|September 29, 2005
No common denominator for breast cancer lymph node metastasisB Weigelt, L F A Wessels, A J Bosma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Correction: Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation AssaysPeter Bouwman, Ingrid van der Heijden, Hanneke van der Gulden, et al.
Cell Research|May 26, 2018
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer modelsZheng Xue, Daniel J Vis, Alejandra Bruna, et al.
Molecular Cancer Therapeutics|March 16, 2019
Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with CisplatinRemco Nagel, Ana Teresa Avelar, Nanne Aben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2024
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung CancerJoris van de Haar, Joanne M Mankor, Karlijn Hummelink, et al.
Nucleic Acids Research|June 10, 2011
Computational identification of insertional mutagenesis targets for cancer gene discoveryJohann de Jong, Jeroen de Ridder, Louise van der Weyden, et al.
Pageof 34